Combination therapy with pulmonary arterial hypertension targeted drugs and immunosuppression can be a useful strategy for sarcoidosis-associated pulmonary hypertension: a case report.
Keiko SumimotoYu TaniguchiNoriaki EmotoKen-Ichi HirataPublished in: European heart journal. Case reports (2020)
This case emphasizes the importance of considering the underlying mechanisms of sarcoidosis-associated PH in order to choose appropriate treatment.